Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients
Catherine Patte(Institut Gustave Roussy), Mitchell S. Cairo(New York Medical College), Jean Michon(Université Paris Sciences et Lettres), Richard Sposto(Children's Hospital of Los Angeles), Martine Raphaël(University of Lausanne), Mary Gerrard(Sheffield Children's Hospital), Keith McCarthy(National Health Service), Ross Pinkerton(Royal Marsden NHS Foundation Trust), Anne Aupérin(Inserm), Sherrie L. Perkins(University of Utah), Claire Weston(University of Leicester)
Cited by 431
Related Papers
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2010|1.9k
Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global Challenge
|Journal of Clinical Oncology|2015|450
Influence of Human Immunodeficiency Virus Infection on Chronic Hepatitis B in Homosexual Men
|Hepatology|1999|445
Randomized Study of Two Chemotherapy Regimens for Treatment of Low-Grade Glioma in Young Children: A Report From the Children's Oncology Group
|Journal of Clinical Oncology|2012|433